Histogenics Corporation

Histogenics Corporation

Histogenics Corporation

Histogenics is a tissue regeneration company developing breakthrough treatmentsfor long-lasting joint repair.
Founded
2000
Raised
$79M
Follow us
Alexa global traffic share
Latest funding
$30,000,000
Post-IPO equity - 2016
$49,000,000
Venture capital (Series C) - 2012
Split Rock Partners BioMed Ventures Sofinnova Ventures
Team Size
10+
Employees
$30,000,000 Post-IPO equity
MassDevice

Histogenics raises $30m for NeoCart regenerative knee treatment